MR-guided SBRT in Synchronous Oligometastatic Prostate Cancer: Toxicity and Preliminary Outcomes

被引：0
|
作者：
Poon, Darren M. C. [1 ]
Yuan, Jing [2 ]
Wong, Oi Lei [2 ]
Yang, Bin [3 ]
Chiu, Sin Ting [4 ]
Chiu, George [4 ]
Cheung, Kin Yin [3 ]
Yu, Siu Ki [3 ]
机构：
[1] Hong Kong Sanat & Hosp, Comprehens Oncol Ctr, Happy Valley, Hong Kong, Peoples R China
[2] Hong Kong Sanat & Hosp, Res Dept, Happy Valley, Hong Kong, Peoples R China
[3] Hong Kong Sanat & Hosp, Dept Med Phys, Happy Valley, Hong Kong, Peoples R China
[4] Hong Kong Sanat & Hosp, Dept Radiotherapy, Happy Valley, Hong Kong, Peoples R China
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 194卷
关键词：
Oligometastatic prostate cancer; MRgRT;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
807
引用
收藏
页码：S2365 / S2367
页数：3
相关论文
共 50 条
  • [1] 1.5T MR-guided SBRT for Oligometastatic Prostate Cancer: Toxicity and Clinical Outcomes
    Poon, D.
    Yuan, J.
    Yang, B.
    Wong, O. L.
    Chiu, S. T.
    Chiu, G.
    Cheung, K. Y.
    Yu, S. K.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1185 - S1186
  • [2] 1.5 T MR-guided SBRT for oligorecurrent prostate cancer: preliminary report of feasibility and PROMs
    Cuccia, F.
    Mazzola, R.
    Figlia, V.
    Rigo, M.
    Nicosia, L.
    Giaj-Levra, N.
    Ricchetti, F.
    Vitale, C.
    Attina, G.
    Pastorello, E.
    Di Paola, G.
    De Simone, A.
    Gurrera, D.
    Naccarato, S.
    Sicignano, G.
    Ruggieri, R.
    Alongi, F.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1138 - S1139
  • [3] Daily adaptive MR-guided SBRT for oligometastatic lymph-nodes:feasibility and preliminary experience
    Rigo, M.
    Cuccia, F.
    Figlia, V.
    Giaj-Levra, N.
    Mazzola, R.
    Nicosia, L.
    Ricchetti, F.
    Gurrera, D.
    De Simone, A.
    Naccarato, S.
    Sicignano, G.
    Ruggieri, R.
    Alongi, F.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1239 - S1240
  • [4] MR-guided daily adapted SBRT for prostate cancer: Acute and late patient reported outcomes
    Nugent, K.
    Sabharwal, A.
    Perna, C.
    Das, P.
    Dallas, N.
    Camilleri, P.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S454 - S455
  • [5] Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer
    J. Schaule
    M. Chamberlain
    L. Wilke
    M. Baumgartl
    J. Krayenbühl
    M. Zamburlini
    M. Mayinger
    N. Andratschke
    S. Tanadini-Lang
    M. Guckenberger
    Radiation Oncology, 16
  • [6] Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer
    Schaule, J.
    Chamberlain, M.
    Wilke, L.
    Baumgartl, M.
    Krayenbuhl, J.
    Zamburlini, M.
    Mayinger, M.
    Andratschke, N.
    Tanadini-Lang, S.
    Guckenberger, M.
    RADIATION ONCOLOGY, 2021, 16 (01)
  • [7] Patient-reported acute urinary toxicity after daily adaptive MR-guided SBRT for prostate cancer
    Willigenburg, T.
    Teunissen, F. R.
    van der Velden, J.
    de Boer, J.
    van Zyp, J. van der Voort
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S506 - S507
  • [8] Toxicity and QoL report of 1.5T MR-guided SBRT for prostate cancer in the first 100 patients
    Cuccia, F.
    Figlia, V.
    Rigo, M.
    Nicosia, L.
    Mazzola, R.
    Giaj-Levra, N.
    Ricchetti, F.
    Attina, G.
    Pastorello, E.
    Vitale, C.
    De Simone, A.
    Gurrera, D.
    Naccarato, S.
    Sicignano, G.
    Ruggieri, R.
    Alongi, F.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S503 - S504
  • [9] Oligometastatic prostate cancer: outcomes and toxicity of stereotactic body radiation therapy (SBRT)
    Gomis Selles, E.
    Munoz Munoz, O.
    Cabrera Roldan, P.
    Delgado Leon, B. D.
    Lopez Guerra, J. L.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1276 - S1278
  • [10] Clinical Outcomes of Prostate SBRT Using Non-adaptive MR-Guided Radiotherapy
    Sandoval, Maria L.
    Rishi, Anupam
    Latifi, Kujtim
    Grass, G. Daniel
    Torres-Roca, Javier
    Rosenberg, Stephen A.
    Yamoah, Kosj
    Johnstone, Peter A. S.
    CANCER CONTROL, 2024, 31
12345